TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Generic drugmaker Mylan completes $1.75B acquisition in India

Thursday, Dec. 5, 2013, 12:01 a.m.
 

Generic drugmaker Mylan Inc. expanded its global manufacturing capability and portfolio of injectable medications with a $1.75 billion acquisition on Wednesday.

Cecil-based Mylan, one of the world's biggest generic pharmaceutical companies, said it completed the purchase of the Agila unit of Indian drugmaker Strides Arcolab Ltd.

The deal, first announced in February, gives Mylan 13 manufacturing plants in six countries and four research and development centers staffed by 400 scientists.

The addition of Agila's portfolio means Mylan offers more than 1,200 injectable drugs across the world, with another 900 products awaiting regulatory approvals, the company said.

Agila's foothold in several emerging markets, including Brazil, India and Southeast Asia, was attractive to Mylan.

“The acquisition of Agila will create a global injectables leader, expanding and strengthening Mylan's existing injectables platform and portfolio, and providing Mylan entry into exciting, new geographic markets,” CEO Heather Bresch said in a statement. “We believe we can generate significant growth from this business.”

Mylan will hold back $250 million in the deal on the condition that Agila satisfy U.S. regulators over problems of one of its Indian manufacturing plants.

In September, the Food and Drug Administration sent a so-called warning letter to Agila as a result of a June inspection at its Bangalore factory that turned up deficient procedures for preventing contamination of products.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or anixon@tribweb.com.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Chrysler recalls up to 792K Jeep SUVs for ignition switch defect
  2. 10 million Americans sought help to enroll in Obamacare
  3. Consumer prices creep up 0.3% in June
  4. Federal appeals courts disagree on Obamacare subsidies
  5. Amwell wastewater site to be shut down
  6. California firm issues nationwide fruit recall
  7. China meat scandal hits Starbucks, Burger King, McDonald’s
  8. New York home  to 389K millionaires
  9. Sluggish growth elsewhere could infect healthy U.S. economy
  10. Judge nixes suit from Empire State Building investors
  11. Latrobe’s Ci Medical Technologies transforms to medical device business
Subscribe today! Click here for our subscription offers.